Paolo Morandi

8.5k total citations · 4 hit papers
100 papers, 6.0k citations indexed

About

Paolo Morandi is a scholar working on Civil and Structural Engineering, Oncology and Building and Construction. According to data from OpenAlex, Paolo Morandi has authored 100 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Civil and Structural Engineering, 35 papers in Oncology and 23 papers in Building and Construction. Recurrent topics in Paolo Morandi's work include Masonry and Concrete Structural Analysis (47 papers), Seismic Performance and Analysis (26 papers) and Structural Behavior of Reinforced Concrete (16 papers). Paolo Morandi is often cited by papers focused on Masonry and Concrete Structural Analysis (47 papers), Seismic Performance and Analysis (26 papers) and Structural Behavior of Reinforced Concrete (16 papers). Paolo Morandi collaborates with scholars based in Italy, United States and Russia. Paolo Morandi's co-authors include Guido Magenes, Sanja Hak, Massimo Cristofanilli, Luca Gianni, Aňa Lluch, Pinuccia Valagussa, Semiglazov Vf, Juan de la Haba-Rodríguez, Elżbieta Starosławska and Vichien Srimuninnimit and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Paolo Morandi

99 papers receiving 5.9k citations

Hit Papers

Efficacy and safety of neoadjuvant pertuzumab and trastuz... 2005 2026 2012 2019 2011 2005 2016 2013 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
    2011 1.5k citations Luca Gianni, Paolo Morandi et al. profile →
  2. Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
    2005 1.4k citations Roman Rouzier, Charles M. Perou et al. Clinical Cancer Research profile →
  3. 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
    2016 555 citations Luca Gianni, Paolo Morandi et al. profile →
  4. Performance of masonry buildings during the Emilia 2012 earthquake
    2013 271 citations Andrea Penna, Paolo Morandi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paolo Morandi Italy 27 3.3k 2.3k 1.3k 929 916 100 6.0k
Takeshi Kishida Japan 38 790 0.2× 1.5k 0.7× 226 0.2× 188 0.2× 2.8k 3.1× 148 4.6k
Toru Shibata Japan 29 285 0.1× 566 0.2× 497 0.4× 348 0.4× 631 0.7× 126 2.6k
Andrés Poveda Spain 39 2.3k 0.7× 594 0.3× 71 0.1× 86 0.1× 909 1.0× 157 5.8k
Muhammed Murtaza United States 19 2.2k 0.7× 4.2k 1.8× 41 0.0× 170 0.2× 2.2k 2.4× 61 5.6k
Guido Rossi Italy 28 376 0.1× 387 0.2× 58 0.0× 78 0.1× 857 0.9× 79 2.2k
Zhenwei Peng China 41 933 0.3× 712 0.3× 13 0.0× 392 0.4× 871 1.0× 190 5.5k
Paola Mazzanti Italy 17 886 0.3× 195 0.1× 10 0.0× 50 0.1× 280 0.3× 70 1.7k
Satoshi Kobayashi Japan 33 421 0.1× 265 0.1× 130 0.1× 1.5k 1.6× 287 0.3× 226 4.4k
Rafael Sirera Spain 26 1.1k 0.3× 920 0.4× 51 0.0× 95 0.1× 1.3k 1.4× 83 2.7k
Stephen Ledbetter United Kingdom 10 183 0.1× 217 0.1× 43 0.0× 57 0.1× 550 0.6× 25 1.2k

Countries citing papers authored by Paolo Morandi

Since Specialization
Citations

This map shows the geographic impact of Paolo Morandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Morandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Morandi more than expected).

Fields of papers citing papers by Paolo Morandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Morandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Morandi. The network helps show where Paolo Morandi may publish in the future.

Co-authorship network of co-authors of Paolo Morandi

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Morandi. A scholar is included among the top collaborators of Paolo Morandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Morandi. Paolo Morandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morandi, Paolo, et al.. (2024). Dynamic shaking table out-of-plane tests on weak masonry infills with and without previous in-plane loading. Journal of Building Engineering. 100. 111670–111670. 3 indexed citations
2.
Bonanno, Laura, Lorenzo Calvetti, Alessandro Dal Maso, et al.. (2024). Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis. Frontiers in Immunology. 15. 1353889–1353889. 3 indexed citations
3.
Bolognini, D., et al.. (2024). Development of a method based on audio waves for fast in-situ out-of-plane dynamic evaluations of the frequencies of masonry infills. Construction and Building Materials. 452. 138874–138874. 2 indexed citations
4.
DeJong, Matthew J., et al.. (2023). Distinct element modeling of the in‐plane response of a steel‐framed retrofit solution for URM structures. Earthquake Engineering & Structural Dynamics. 52(10). 3030–3052. 15 indexed citations
5.
Guerrini, Gabriele, et al.. (2023). PRELIMINARY RESULTS OF A SHAKING-TABLE DYNAMIC TEST ON A REPAIRED AND ENHANCED REINFORCED CONCRETE INFILLED STRUCTURE. COMPDYN Proceedings. 2841–2856. 1 indexed citations
6.
7.
Gion, Massimo, Stefano Guzzinati, Paolo Morandi, et al.. (2022). Use of Routine Health Datasets to Assess the Appropriateness of Diagnostic Tests in the Follow-Up of Breast Cancer Patients: A Population-Based Study on 3930 Patients. Risk Management and Healthcare Policy. Volume 15. 1087–1100. 1 indexed citations
8.
Zambetti, Milvia, Filippo Montemurro, Paolo Morandi, et al.. (2018). Safety profile of subcutaneous trastuzumab for the treatment of patients with HER2-positive early or locally advanced breast cancer: primary analysis of the SCHEARLY study. European Journal of Cancer. 105. 61–70. 9 indexed citations
9.
Morandi, Paolo, Sanja Hak, & Guido Magenes. (2017). Mechanical characterization and force-displacement hysteretic curves from in-plane cyclic tests on strong masonry infills. Data in Brief. 16. 886–904. 10 indexed citations
10.
Morandi, Paolo, Sanja Hak, & Guido Magenes. (2013). Simplified Out-of-plane Resistance Verification for Slender Clay Masonry Infills in RC Frames. 23 indexed citations
11.
Cristofanilli, Massimo, Paolo Morandi, James M. Reuben, et al.. (2008). Imatinib mesylate (Gleevec®) in advanced breast cancer-expressing C-Kit or PDGFR-β: clinical activity and biological correlations. Annals of Oncology. 19(10). 1713–1719. 75 indexed citations
12.
Cabıoğlu, Neslihan, Yun Yun Gong, R. Islam, et al.. (2007). Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer. Annals of Oncology. 18(6). 1021–1029. 117 indexed citations
13.
Morandi, Paolo. (2006). Biological agents and gemcitabine in the treatment of breast cancer. Annals of Oncology. 17. v177–v180. 6 indexed citations
14.
Rouzier, Roman, Charles M. Perou, W. Fraser Symmans, et al.. (2005). Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy. Clinical Cancer Research. 11(16). 5678–5685. 1414 indexed citations breakdown →
15.
16.
Nasa, Giorgio La, C. Annaloro, Maurizio Marconi, et al.. (2002). Harvesting of Autologous Blood Stem Cells after a Mobilising Regimen with Low-dose Cyclophosphamide. Leukemia & lymphoma. 43(10). 1957–1960. 12 indexed citations
17.
Morandi, Paolo, et al.. (2001). Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m2) cyclophosphamide. Bone Marrow Transplantation. 28(3). 277–282. 69 indexed citations
18.
Cocconi, Giorgio, Giancarlo Bisagni, Guido Ceci, et al.. (1999). Three new active cisplatin‐containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial. Breast Cancer Research and Treatment. 56(2). 123–130. 11 indexed citations
19.
Fornasiero, A., Otello Daniele, Cristina Ghiotto, et al.. (1990). Chemotherapy of invasive thymoma.. Journal of Clinical Oncology. 8(8). 1419–1423. 90 indexed citations
20.
Fiorentino, Mario V., Otello Daniele, Paolo Morandi, et al.. (1988). Intrapericardial instillation of platin in malignant pericardial effusion. Cancer. 62(9). 1904–1906. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takeshi Kishida Breakdown of academic impact, for papers by Toru Shibata Breakdown of academic impact, for papers by Andrés Poveda Breakdown of academic impact, for papers by Muhammed Murtaza Breakdown of academic impact, for papers by Guido Rossi Breakdown of academic impact, for papers by Zhenwei Peng Breakdown of academic impact, for papers by Paola Mazzanti Breakdown of academic impact, for papers by Satoshi Kobayashi Breakdown of academic impact, for papers by Rafael Sirera Breakdown of academic impact, for papers by Stephen Ledbetter
Rankless by CCL
2026